Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Monster @ HZNP
Coming up on $40 with a huge gain of 6%!
This stock has had a solid run for traders and longs the past 18 months and the run is not over..my average is under $10 and lookin for $50!
Investor 100
An all stock acquisition of DEPO by HZNP should create a PPS for HZNP that is on steroids if it is successful. An additional six new drugs with current annual sales of $400,000,000.00 added to HZNP'S seven current drugs at no monetary cost (only share dilution to shareholders) should create a market cap for the combined company of well over Ten Billion. It appears that Mr Walbert is working overtime for HZNP shareholders.
ALL THE BEST
GULL
STeady @ HZNP
Closing to $40 and the acquisition of DEPO!
On July 21, 2015, Horizon Pharma plc issued a press release announcing it has increased the value of its all-stock proposal to acquire all of the outstanding shares of common stock of Depomed, Inc. from $29.25 per share to $33.00 per share. A copy of the press release is attached hereto as Exhibit 99.1. The foregoing description is qualified in its entirety by reference to the text of such press release and is incorporated herein by reference and constitutes part of this report.
The information contained in this Item 8.01 and the attached Exhibit 99.1 are furnished to and not filed with the Securities and Exchange Commission. The foregoing description is qualified in its entirety by reference to the text of such press release and is incorporated herein by reference and constitutes part of this report.
Investor 100
40s right around the corner
Boom keeps on coming
Moving along @ HZNP
Another spike inching closer to $40 ( .98% )...holding to $50!
Solid MOMO run the past 18 months for both traders and investors.
Investor 100
Upward @ HZNP
Nice 2%+ today in choppy waters despite the news of a DEPO buyout that got declined ( counter-offer coming ?) going much higher..
DepoMed (DEPO) Stock Declines After Rejecting Horizon Pharma's Latest $3 Billion Offer
http://www.thestreet.com/story/13212242/1/depomed-depo-stock-declines-after-rejecting-horizon-pharmas-latest-3-billion-offer.html?puc=yahoo&cm_ven=YAHOO
Investor 100
Admittedly I was hoping for a bigger dip but it didnt happen...thats a solid sign in my opinion..."safe money" if there is such a thing.
Stockcharts @ HZNP
Any pull back is an opportunity to buy more or take a position it did not happen today when the market was down 350 points!
Stock was mentioned on MAD Money Cramer... nice plug as a buy - no kidding!
This has been a dream traders and investors stock the past 18 months and believe we are going much higher!
Investor 100
Add the dip @ HZNP
Like those dips to add a few more as we move much higher!
Business Summary
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. It offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications; PENNSAID for the treatment of pain of OA of the knee; and VIMOVO, a proprietary fixed-dose multi-layer delayed-release tablet for the relief of the signs and symptoms of OA, RA, and ankylosing spondylitis (AS). The company also provides RAYOS/LODOTRA, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active RA in adults when accompanied by morning stiffness, as well as for the treatment of polymyalgia rheumatica, psoriatic arthritis, AS, asthma, chronic obstructive pulmonary disease, and various other conditions. Horizon Pharma plc was founded in 2005 and is headquartered in Dublin, Ireland.
http://www.horizonpharma.com/
Investor 100
Hedge Funds-News
Deerfield Management’s Top Health Stocks ~ Auspex Pharmaceuticals Inc (ASPX), Horizon Pharma PLC (HZNP), AbbVie Inc (ABBV)
Read more at http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/#ROKhb1QppOrzXKMM.99
Deerfield Management’s second-largest health investment was in Horizon Pharma PLC (NASDAQ:HZNP), in which it owns 12.79 million shares valued at $332.23 million. The specialty biopharmaceutical company has a market cap of $5.02 billion and its shares currently trade at $32.28. Horizon Pharma completed the acquisition of Horizon Therapeutics Inc (NASDAQ:HPTX) on May 7 with a tender offer for 86% of the outstanding shares of the latter. With this acquisition, Horizon Pharma PLC (NASDAQ:HZNP) added two successful medicines for the treatment of urea cycle disorders, RAVICTI and BUPHENYL, to its portfolio. The biopharmaceutical company reported net sales of $113.1 million during the first quarter of 2015 with a net loss of $19.6 million. Broadfin Capital and Healthcor Management LP are two other health-focused investment firms that hold major positions in Horizon Pharma PLC (NASDAQ:HZNP), which has gained an even-more-impressive 152% year-to-date.
Read more at http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/#ROKhb1QppOrzXKMM.99
http://www.insidermonkey.com/blog/deerfield-managements-top-health-stocks-auspex-pharmaceuticals-inc-aspx-horizon-pharma-plc-hznp-abbvie-inc-abbv-350499/
Investor 100
Transactions @ HZNP
Looking forward to the second half of 2015!
On Friday's call with analysts, Chief Business Officer Robert Carey said Horizon still has $500 million it could spend on acquisitions. "We've got sufficient capacity to execute on our plan right now and hope to continue to be active in the marketplace."
http://news.investors.com/050815-751719-hznp-raises-guidance-after-hptx-buyout.htm?ven=yahoocp&src=aurlled&ven=yahoo
Horizon Pharma plc Completes Hyperion Therapeutics Acquisition
Horizon Pharma plc Announces Acquisition of U.S. Rights to PENNSAID(R) 2% From Nuvo Research Inc.
Horizon Pharma completes acquisition of Vidara Therapeutics International LTD
Horizon Pharma announces definitive agreement to acquire Vidara Therapeutics International LTD
Horizon Pharma announces agreement to acquire U.S. rights to VIMOVO
Horizon Therapeutics completes merger with Nitec Pharma
http://www.horizonpharma.com/transactions/
Investor 100
Horizon Pharma plc to Participate in Two Conferences in June
http://finance.yahoo.com/news/horizon-pharma-plc-participate-two-144500054.html
Investor 100
Any thoughts on the recent suit against HZNP alleging that its' principle money making drug was erroneously approved because it was obvious in that it merely combined an antacid with a pain killer? The suit states both were available without a prescription and that anyone could simply take both drugs at once with the result that folks would feel just as well as if they had taken the HZNP drug.
If the suit succeeds it would be diastrous for HZNP.
Corporate Presentation @ HZNP
Impressive indeed!
http://files.shareholder.com/downloads/AMDA-EFACL/158393936x0x807937/668F9B8B-13FA-41E8-A041-B66CA54BAC83/HZNP_Corporate_Presentation.pdf
Investor 100
We should see close to a 52 week high going into tomm close. Fins out BO Friday morning.
GLTA
Horizon Pharma plc Names John B. Thomas Executive Vice President, Strategy and Investor Relations
http://finance.yahoo.com/news/horizon-pharma-plc-names-john-110000719.html
Investor 100
just won't quit. The gravy train is not over yet either.
Upward @ HZNP
Up 5% today!
Tremendous run in 2015 ( 2014 as well )and the train has not yet left the station!
http://www.thestreet.com/story/13115961/1/horizon-pharma-hznp-stock-rises-in-after-hours-trading-following-pricing-of-secondary-offering.html?puc=yahoo&cm_ven=YAHOO
The dip on the offering came and went...bought more too!
Investor 100
Mad Money Cramer @ HZNP
Nice plug on HZNP tonight @ Mad Money!
Investor 100
Horizon Pharma (HZNP) Stock Falls in After-Hours Today Following Public Share Offering Announcement
Loading up more on the dip...original cost at $8.50...going much higher!
http://www.thestreet.com/story/13110549/1/horizon-pharma-hznp-stock-falls-in-after-hours-today-following-public-share-offering-announcement.html?puc=yahoo&cm_ven=YAHOO
Investor 100
Moving higher @ HZNP
We commend the FDA for granting Fast Track designation for ACTIMMUNE in Friedreich's ataxia to potentially help treat patients suffering from this debilitating disorder, for which there are no FDA approved treatments available," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc. "We look forward to continuing our ongoing clinical development program as we evaluate ACTIMMUNE in this patient population."
Investor 100
Horizon Pharma plc Receives FDA Fast Track Designation for ACTIMMUNE(R) in the Treatment of Friedreich's Ataxia
Solid News to take much higher!
http://finance.yahoo.com/news/horizon-pharma-plc-receives-fda-110000289.html
Investor 100
targets raised to 42-50. All "buy" ratings at the moment.
Horizon Pharma Soars On Q4 Beat, Guidance Raise
Read More At Investor's Business Daily: http://news.investors.com/technology/022715-741245-hznp-stock-hits-high-on-q4-earnings.htm#ixzz3T07z1T6m
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook
http://news.investors.com/022715-741245-hznp-stock-hits-high-on-q4-earnings.htm?ven=yahoocp&src=aurlled&ven=yahoo
beast mode, the scary thing is though, this company is only just starting to expand
timmmy walton is dam man!!
EURNINGS THIS FRIDAY :) GL
what is going on here?! i was targeting 2nd quarter for a pop. not complaining here, could be as a result of Cramer giving some love to HZNP
New Office in Chicago @ HZNP
Horizon Pharma plc Expands U.S. Headquarters With Opening of Chicago Office
Initial Expansion Will Bring More Than 25 Jobs to the City of Chicago
http://finance.yahoo.com/news/horizon-pharma-plc-expands-u-130000183.html
Investor 100
Followers
|
41
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
689
|
Created
|
09/06/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |